For most people, living with autoimmune disease or inflammatory arthritis means living with multiple medications.
According to several studies smokers are more likely to develop RA and suffer more severe consequences.
Simponi®(golimumab)is one of five marketed TNF inhibitors(TNFi) that is FDA approved for use in psoriatic arthritis(PsA)
Doctors evaluated mobility, self-care, and activities of daily living in Cosentyx treated patients.
Selective JAK Inhibitors to expand treatment option for ankylosing spondylitis.
Citrate has been removed, the needle size has been reduced, and the overall amount of fluid injected has been decreased.
Study demonstrates that Taltz IL-17 inhibition improves psoriatic arthritis associated ethesitis and dactylitis.